1. 1) Amendment of Act No.69 of 2000: Act on Prevention of Radiation Hazards due to Radioisotopes, etc.
2. 2) Takada, S., Muto, T., Ito, N., Kitahara, A., Chisaka, H., Kuze, I., Tateishi, T., Nakamura, Y., Ikeda, M.: An Estimation for the Dispersal Rates of Radioactive Materials under Various Handling, Radioisotopes, 32, 260-269 (1983) (in Japanese).
3. 3) McDevitt, M. R., Sgouros, G., Finn, R. D., Humm, J. L., Jurcic, J. G., Larson, S. M., Scheinberg, D. A.: Radioimmunotherapy with Alpha-Emitting Nuclides, Eur. J. Nucl. Med., 25, 1341-1351 (1998).
4. 4) Bayer AG HP, https://www.investor.bayer.de/en/news/investor-news/.
5. 5) Guérard, F., Gestin, J.-F., Brechbiel, W.: Production of [211At]-Astatinated Radiopharmaceuticals and Applications in Targeted α-Particle Therapy, Cancer Biother. Radiopharm., 28, 1-20 (2013).